Skip to content
Bravos Capital logo
Private Equity

Updated:

Bravos Capital

Bravos Capital is a private investment firm focused on special situations and high-growth businesses in various sectors. It has made 8 investments.

Overview

Bravos Capital is a private investment firm focused on special situations and high-growth businesses in various sectors. It has made 8 investments. Bravos Capital invested in Wild Bioscience as part of their Series A on October 16, 2025.

General information

Firm type

Private Equity

Year founded

2018

Location

Region

North America

Country

United States

City

Los Angeles

Corporate office

Los Angeles, CA, United States

Frequently asked questions

What investment stage does Bravos Capital target?

Bravos Capital targets growth-stage investments. The firm's strategy is built around providing equity to companies that have moved beyond the startup phase and are looking to expand. Specific sub-stage preferences within growth equity are not publicly specified.

What sectors does Bravos Capital focus on?

A specific sector focus has not been published for Bravos Capital. The firm's investment mandate is broadly defined around growth-stage companies. It has not publicly excluded any particular industry.

Who manages Bravos Capital?

The principals and key decision-makers at Bravos Capital have not been publicly identified through the firm's website or primary professional disclosures. No named investment committee members or managing partners are available in the consulted sources.

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Private Equity profiles